• Announcements

    • Joelf

      Upgraded Sclero Forums!   05/18/2017

      Welcome to the Upgraded and Redesigned Sclero Forums!!   Our Forums are even better and more up to date than before.   Happy Posting to all our Members!!
Sign in to follow this  
Followers 0

EVOXAC Efficacy and Clinical Studies

2 posts in this topic

EVOXAC Efficacy and Clinical Studies.


EVOXAC is a cholinergic agonist which binds to muscarinic receptors and significantly improves salivary flow for patients suffering from dry mouth associated with Sjögren's syndrome. Nine clinical trials have shown EVOXAC to be both safe and effective. Evoxac. April, 2011. (Also see: Sjogrens)


This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.

Janey Willis

ISN Support Specialist

(Retired) ISN Assistant Webmaster

(Retired) ISN News Director

(Retired) ISN Technical Writer for Training Manuals

International Scleroderma Network (ISN)

Share this post

Link to post
Share on other sites

I've been on this drug before. It does increase saliva flow; however, the down side is they are expensive pills and you have to take 2 or 3 per day. I found that if I took more than 1 per day, I would get sick to my stomach. They also make you sweat profusely after taking the pill for about the first couple of hours after taking. But again, they did help increase saliva production.

Share this post

Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
Sign in to follow this  
Followers 0